Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912282-25-000055
Filing Date
2025-01-24
Accepted
2025-01-24 13:58:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4950
  Complete submission text file 0000912282-25-000055.txt   6564
Mailing Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8
Business Address 3204-4464 MARKHAM ST. VICTORIA A1 V8Z 7X8 6048060626
ImmunoPrecise Antibodies Ltd. (Subject) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94108 | Film No.: 25553468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FABRIEKSSTRAAT 7 HAMONT-ACHEL C9 3930
Business Address FABRIEKSSTRAAT 7 HAMONT-ACHEL C9 3930 0032 596 613483
Charmquark TWEE (Filed by) CIK: 0001930122 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A